Skip to main content

Table 2 Chemo susceptibility of TUBO and TUBO-P2J cells

From: Intratumoral heterogeneity impacts the response to anti-neu antibody therapy

Chemoreagent IC50
TUBO TUBO-P2J
Carboplatin 0.22 mg/ml 4.97 mg/ml
Cisplatin 4.2 ug/ml 3.53 ug/ml
Cyclophosphamide 0.15 mg/ml 1.93 mg/ml
Daunorubicin UD 326 ng/ml
Doxoruibicin 56.9 ng/ml 306.6 ng/ml
Epirubicin 2.87 ng/ml 40.3 ng/ml
Etoposide 84 ug/ml 76.63 ug/ml
Gemcitabin 0.55 ng/ml 6.4 ng/ml
Idarubicin UD 0.98 ug/ml
Irinotecan 1.7 mg/ml 0.95 mg/ml
Oxaliplatin 0.26 ug/ml 34.55 ug/ml
Vinorelbine 0.23 ug/ml 6.8 ug/ml
  1. UD under detected.